skip to content
Detailed Quote
5i Report
Rating
B+

Review of Well Health Technologies

APR 25, 2024 - WELL is one of the main serial acquirers that operates in the healthcare market in Canada. WELL has been an active user of debt and equity issuance to implement its acquisitive growth strategy, which could be potentially a risk for dilution or unsustainable leverage level. The guidance for FY2024 revenue growth is impressive, indicating a healthy growth profile. The low valuation multiple relative to historical averages and its peer group is also appealing for a long-term hold here. We think investors could do well owning WELL over the next three to five years as the company improves profitability and the market re-rates its valuation, we are maintaining our rating of ‘B+’.

Download Report
Company Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Hello Team, Seams like every couple weeks something in the world changes the script (Trump, Tariffs, Deepseek, etc). Can you please rank the above 12 stocks from best too worst for the next 2-3 years. No worries about size of company or industry. Thanks so much!
Read Answer Asked by Kevin on February 03, 2025
Q: Another question on my semi annual balancing exercise. With the understanding that the rest of my portfolio consists of conservative growth, dividend paying large caps and that I am looking at a 3 to 5 year time frame. Please indicate the those companies you would carry at a 5 % ish level, those that you would carry at a 2% to 3% level and those that you might not carry at all. Much appreciated ram
Read Answer Asked by Ray on January 27, 2025
Insiders
Share Information
News and Media